Eye Diseases Completed Phase 2 Trials for Valproic acid (DB00313)

IndicationStatusPhase
DBCOND0030511 (Eye Diseases)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01399515Efficacy and Safety of Oral Valproic Acid for Retinitis PigmentosaTreatment